Intracranial metastatic disease rarely involves the pituitary: retrospective analysis of 935 metastases in 155 patients and review of the literature

被引:24
作者
Marsh, James C. [1 ]
Garg, Shalini [1 ]
Wendt, Julie A. [2 ]
Gielda, Benjamin T. [1 ]
Turian, Julius V. [1 ]
Herskovic, Arnold M. [1 ]
机构
[1] Rush Univ, Med Ctr, Dept Radiat Oncol, Chicago, IL 60612 USA
[2] Silver Cross Hosp, Joliet, IL USA
关键词
Pituitary; Intracranial metastatic disease; Endocrinologic dysfunction; CELL LUNG-CANCER; PROPHYLACTIC CRANIAL IRRADIATION; BRAIN METASTASES; DIABETES-INSIPIDUS; PROGNOSTIC-FACTORS; SURGICAL-TREATMENT; MOYAMOYA-SYNDROME; GLAND METASTASIS; RADIATION; RADIOTHERAPY;
D O I
10.1007/s11102-010-0229-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We present a case report of a patient recently treated at our institution for an isolated non-small cell lung cancer metastatic lesion to the sella, report the lack of involvement of the pituitary gland in a large single-institution series of treated intracranial parenchymal metastases, and review the pertinent literature. We reviewed cranial imaging studies (CT and MRI) for 935 metastases in 155 patients treated at our institution over the previous 3 years for intracranial metastatic disease. Special attention was paid to the skull base to document the presence of any metastatic disease involving the pituitary gland, infundibular stalk, sella turcica (including anterior and posterior clinoids), or diaphragm sellae. We found no other involvement of the pituitary gland or other sellar structures by metastatic disease in this series. Intracranial metastatic disease rarely involves the pituitary gland and infundibular stalk parenchyma, suggesting that this structure may be safely omitted from the treatment field during WBRT and prophylactic cranial irradiation (PCI). This treatment approach should reduce the late sequelae of treatment to this critical organ.
引用
收藏
页码:260 / 265
页数:6
相关论文
共 60 条
[1]   METASTATIC TUMORS TO THE PITUITARY [J].
AABERG, JM ;
KAY, M ;
STERNAU, L .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1995, 119 (06) :779-785
[2]   Hypothalamic-pituitary dysfunction after irradiation of nonpituitary brain tumors in adults [J].
Agha, A ;
Sherlock, M ;
Brennan, S ;
O'Connor, SA ;
O'Sullivan, E ;
Rogers, B ;
Faul, C ;
Rawluk, D ;
Tormey, W ;
Thompson, CJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (12) :6355-6360
[3]  
Alacacioglu A, 2008, TUMORI J, V94, P765
[4]   Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission [J].
Aupérin, A ;
Arriagada, R ;
Pignon, JP ;
Le Péchoux, C ;
Gregor, A ;
Stephens, RJ ;
Kristjansen, PEG ;
Johnson, BE ;
Ueoka, H ;
Wagner, H ;
Aisner, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (07) :476-484
[5]   Neural stem cell-preserving external-beam radiotherapy of central nervous system malignancies [J].
Barani, Igor J. ;
Cuttino, Laurie W. ;
Benedict, Stanley H. ;
Todor, Dorin ;
Bump, Edward A. ;
Wu, Yan ;
Chung, Theodore D. ;
Broaddus, William C. ;
Lin, Peck-Sun .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 68 (04) :978-985
[6]  
Bertola Giorgio, 2007, Recenti Progressi in Medicina, V98, P87
[7]   Surgical treatment of primary lung cancer with synchronous brain metastases [J].
Billing, PS ;
Miller, DL ;
Allen, MS ;
Deschamps, C ;
Trastek, VF ;
Pairolero, PC .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2001, 122 (03) :548-553
[8]   PROGRESSIVE CEREBRAL OCCLUSIVE DISEASE AFTER RADIATION-THERAPY [J].
BITZER, M ;
TOPKA, H .
STROKE, 1995, 26 (01) :131-136
[9]   STROKE AFTER PITUITARY IRRADIATION [J].
BOWEN, J ;
PAULSEN, CA .
STROKE, 1992, 23 (06) :908-911
[10]   Cerebrovascular mortality in patients with pituitary adenoma [J].
Brada, M ;
Ashley, S ;
Ford, D ;
Traish, D ;
Burchell, L ;
Rajan, B .
CLINICAL ENDOCRINOLOGY, 2002, 57 (06) :713-717